ACTC science and portfolio of patents are likely worth billions. We need the reverse split so institutional investors can make investments. Over time 12 to 24 months if positive results are reinforced by all the new enrolled patients to be injected, the share price will more than quadruple [that's the reverse split price, what ever that price is]. ACTC closed up a little at 0.08 on 1.5 million shares. The three month avg. volume is 6.8 million shares.
Geron closed up 3 cents at $1.42 on only 369,563 shares. The three month avg. volume 698,677 shares. With no news, there's no interest in this company. That said the share price will go lower until there is good news, THE DEAL or the 6 Phase two trials.
AAPL down $3.03 to closed at $562.29 on 11.7 million shares. The three month avg. volume is 24 million shares. Still think it goes higher soon.
Good luck in this rigged casino,
No comments:
Post a Comment